AJP - GI Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Gastrointest Liver Physiol 293: G475-G483, 2007. First published June 7, 2007; doi:10.1152/ajpgi.00072.2007
0193-1857/07 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/2/G475    most recent
00072.2007v2
00072.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leng, S.
Right arrow Articles by Black, D. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leng, S.
Right arrow Articles by Black, D. D.

MUCOSAL BIOLOGY

Hepatocyte nuclear factor-4 mediates apolipoprotein A-IV transcriptional regulation by fatty acid in newborn swine enterocytes

Shuangying Leng, Song Lu, Ying Yao, Zhisheng Kan, Gabriel S. Morris, Brad R. Stair, Mathew A. Cherny, and Dennis D. Black

Children's Foundation Research Center of Memphis at Le Bonheur Children's Medical Center, Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee

Submitted 10 February 2007 ; accepted in final form 6 June 2007


   ABSTRACT
TOP
 ABSTRACT
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Hepatocyte nuclear factor-4{alpha} (HNF-4{alpha}) regulates transcription of several genes involved in lipid metabolism, including that of apolipoprotein (apo) A-IV, which is tightly regulated by lipid absorption and enhances enterocyte chylomicron secretion. Studies were performed to define the role of HNF-4{alpha} in the regulation of apo A-IV gene transcription by dietary fatty acid in neonatal swine small intestine. HNF-4{alpha} mRNA was expressed in liver > intestine > kidney in suckling, weanling, and weaned pigs. Jejunal HNF-4{alpha} mRNA and protein and apo A-IV and swine microsomal triglyceride transfer protein (MTP) large subunit mRNA expression were induced in parallel in 2-day-old swine by a 24-h high-fat intraduodenal infusion. In IPEC-1 cells, incubation with oleic acid (OA) resulted in coordinate induction of both HNF-4{alpha}, apo A-IV, and MTP mRNA, similar to that observed in vivo. When HNF-4{alpha} expression was driven by doxycycline by using the TET-On system in the absence of OA to observe the effect of HNF-4{alpha} directly on apo A-IV and MTP mRNA levels in the absence of other factors that might be concomitantly induced by fatty acid absorption, apo A-IV and MTP expression were increased. In luciferase reporter gene assays in IPEC-1 cells using apo A-IV/C-III intergenic region constructs, TET-On-regulated HNF-4{alpha} expression without OA increased luciferase activity, and incubation with OA did not further increase activity. These data suggest that acute induction of the apo A-IV and MTP genes by dietary lipid in newborn intestine occurs, at least in part, via ligand-independent transactivation by HNF-4{alpha} that is itself induced by a lipid-mediated mechanism.

apo B; IPEC-1 cells; lipid absorption; microsomal triglyceride transfer protein; neonate; oleic acid

APOLIPOPROTEIN A-IV is a lipid-binding polypeptide synthesized in the small intestine and is tightly regulated by lipid absorption (1, 5, 22). Although myriad extraintestinal functions have been proposed (11, 12, 14, 33, 45), in the enterocyte apo A-IV appears to play a role in the regulation of chylomicron assembly and secretion. Our laboratory (27, 28) has previously demonstrated that increased expression of apo A-IV in a newborn swine intestinal epithelial cell line (IPEC-1) results in the basolateral secretion of larger chylomicrons transporting an increased amount of lipid. In the newborn piglet, acute dietary lipid absorption strongly induces intestinal apo A-IV expression at the transcriptional level (5, 6, 30). However, after weaning this induction is considerably blunted, suggesting a teleological role for apo A-IV in the absorption of a high dietary lipid load, such as that found in breast milk during the suckling period. Therefore, there is considerable interest in delineating the mechanisms of apo A-IV gene regulation by dietary lipid.

The genes for apolipoproteins A-V, A-IV, C-III, and A-I form a cluster on chromosome 11 in the human (23, 38). The apo C-III gene is located downstream from the apo A-I gene and upstream from the apo A-IV gene. The apo A-V gene is located 28 kB downstream of the apo A-IV gene and is transcribed in the same direction as apo A-IV and A-I. The apo C-III gene is transcribed in the opposite direction to that of the other three genes. All four genes are involved in several aspects of lipid metabolism. Tissue-specific and basal regulation of apo A-I, C-III, and A-IV gene transcription has been the focus of extensive study, and relevant cis- and trans-acting factors have been identified (3, 49). Of particular importance in the regulation of the basal and spatial expression of the apo A-IV gene in the small intestine are the proximal apo A-IV promoter (–700/–310) and the distal apo C-III enhancer (–890/–500) regions and associated trans-acting transcription factors (2, 8, 25, 26, 37). However, the regulatory factors involved in lipid-mediated induction of apo A-IV gene expression are poorly understood.

Hepatocyte nuclear factor-4{alpha} (HNF-4{alpha}) is a nuclear receptor that regulates transcription of numerous genes, including several involved in lipid and glucose metabolism (17, 42). In the small intestine, HNF-4{alpha} appears to be a central regulator of gene expression during enterocyte differentiation (43). Although HNF-4{alpha} is capable of constitutive transcriptional activation independent of ligand binding, potential endogenous HNF-4{alpha} activating ligands have been identified in several studies. There is evidence that these ligands may include fatty acids and fatty acyl CoAs (18, 19), and X-ray crystallography studies have revealed that HNF-4{alpha} has a bound fatty acid in a ligand-binding pocket (10). However, this binding pocket appears to be too small to accommodate fatty acyl CoAs (7). Furthermore, this bound fatty acid was not exchangeable with exogenous fatty acids and was required to stabilize the protein for crystallization (46). Collectively, these data suggest that the bound fatty acid may function as a structural cofactor for HNF-4{alpha}, rather than a ligand activator. Therefore, a regulatory role for bound fatty acids and fatty acyl CoAs as ligands in the activation of HNF-4{alpha} remains controversial (21).

Recent studies have defined a role for HNF-4{alpha} in the transcriptional regulation of apo A-IV in the enterocyte, including the basal spatial expression of apo A-IV in the small intestine with restriction of expression to the villus and a proximal to distal gradient via interaction with the apo A-IV gene proximal promoter and distal apo C-III gene enhancer (2, 37). Peignon et al. (32) demonstrated that E-cadherin-dependent cell adhesion in Caco-2 cells controls the abundance of HNF-4{alpha}, which in turn regulates apo A-IV expression. However, data supporting a role for HNF-4{alpha} participation in dietary lipid-mediated regulation of intestinal apo A-IV transcription are scarce. Recently, lipid micelles containing fatty acids incubated in the apical medium compartment of Caco-2 cells were shown to enhance apo A-IV transcription and simultaneously increase HNF-4{alpha} binding to probes containing the apo A-IV proximal promoter/apo C-III distal enhancer sequences (9). In the present studies, we focused on defining the role of HNF-4{alpha} in the regulation of intestinal apo A-IV expression in newborn swine enterocytes in response to lipid absorption using both in vivo and in vitro models.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Materials. Oleic acid (C18:1n-9; OA) and essentially fatty acid-free bovine serum albumin were purchased from Sigma Chemical (St. Louis, MO). Unless otherwise specified, all other chemicals were molecular biology grade and were purchased from Sigma.

Cloning and sequencing of full-length swine HNF-4{alpha} cDNA. Total RNA from swine liver was used for cDNA synthesis by using the SMART RACE cDNA amplification kit according to manufacturer's instructions (BD Biosciences Clontech, Palo Alto, CA). Gene-specific primers were as follows: 5' RACE primer, 5'-TCTTGATCTTGCCCGGGTCGCTCAAC-3'(antisense, nt 876 to 901); 3' RACE primer, 5'-ACGCCTGCCTCAAAGCCATCATCTTC-3' (sense, nt 830 to 855).

Both 5' and 3' RACE PCR products were cloned into the TA vector for sequencing. The following primers were then used for full length HNF-4{alpha} cloning by high-fidelity PCR: forward, 5'-GGACGGTTTGAAACCCAGGAA-3'(sense, nt –170 to –150); reverse, 5'-AGTTGTCCAAGGCAGCAGAG-3' (antisense, nt 1628 to 1647).

Briefly, 1 µl of cDNA, 5 µl of 10x buffer, 5 µl of PCR enhancer solution, 1.5 µl of 50 mM dNTP mixture, 25 pmol of each primer and 1 µl of Platinum Pfx DNA polymerase (Invitrogen, Carlsbad, CA) were used in a 50-µl reaction mixture. PCR was carried out at 94°C for 2 min, followed by 18 cycles of 10 s at 94°C, 15 s at 60°C, and 2 min at 68°C. A 7-min incubation at 68°C was added to the last cycle. The PCR products were cloned for sequencing confirmation.

Animals. Female swine were obtained from Tyson Farms, Plummerville, AR, and used for tissue harvest on the day of arrival. The University of Tennessee Health Science Center Institutional Animal Care and Use Committee approved this protocol. Two-day-old newborn, 3-wk-old weanling, and 2-mo-old weaned animals were fasted for 4–6 h from their last regular breast milk or chow feeding, followed by euthanasia by intravenous pentobarbital overdose. The abdominal cavity was quickly opened for harvest of tissue samples. Samples of jejunum were taken 5 cm distal to the ligament of Treitz for RNA extraction and protein homogenate preparation. A wedge of the anterior right lobe of the liver was similarly sampled. Samples were also taken from kidney, quadriceps femoris skeletal muscle, and intra-abdominal adipose tissue.

To study the short-term (24 h) physiological regulation of HNF-4{alpha} and apo A-IV expression by dietary lipid in newborn swine small intestine, 2-day-old female swine were surgically fitted with duodenal catheters exiting through dorsal swivel tethers as previously described (4). Animals were allowed to recover for 24 h while receiving a glucose-saline (5% glucose in 45 mM NaCl and 20 mM KCl) duodenal infusion at 100 ml·kg–1·24 h–1, followed by infusion as previously described of either dilute Vivonex (Norwich Eaton Pharmaceuticals, Norwich, NY), a low-fat elemental formula, or Intralipid (Cutter, Berkeley, CA), a lipid emulsion containing primarily 18-carbon unsaturated fatty acids. Infusions were isocaloric and at a rate of 50 kcal·kg–1·24 h–1 (4). At the end of 4- and 24-h infusions, the animals were euthanized, and jejunal samples were taken as described above.

IPEC-1 cell culture. The derivation of the IPEC-1 cell line has been described previously (15). Cells from passages 25 to 80 were used in these studies, and all cell culture was carried out at 37°C in an atmosphere containing 5% CO2. Undifferentiated IPEC-1 cells were maintained in serial passage in plastic culture flasks (75 cm2, Corning Glassworks, Corning, NY) in growth medium: Dulbecco's modified Eagle's medium/F12 medium (GIBCO-BRL, Grand Island, NY) supplemented with 5% FBS (GIBCO-BRL), insulin (5 µg/ml), transferrin (5 µg/ml), selenium (5 ng/ml) (ITS Premix, BD Biosciences, Bedford, MA), epidermal growth factor (5 µg/ml) (BD Biosciences), penicillin (50 µg/ml), and streptomycin (4 µg/ml) (GIBCO-BRL). To induce differentiation, undifferentiated cells were harvested by trypsinization, and 2 x 106 cells/well were plated on 75-mm-diameter collagen-coated filters (3.0-µm pore size) in Transwell culture plates (Costar, Corning, Corning, NY). Cells were maintained in serum-containing growth medium for 48 h and then switched to the same medium containing 10–7 M dexamethasone (Sigma), but without FBS. Medium was then changed every 2 days. We have previously shown that after 10 days, IPEC-1 cells exhibit enterocytic features, including polarization with well-defined microvilli facing the apical medium (15). Cellular membrane integrity was assessed by measurement of apical medium lactate dehydrogenase activity (Sigma).

Development of IPEC-1 cells with tetracycline-regulatable HNF-4{alpha} expression. Undifferentiated IPEC-1 cells were plated and grown to 50% confluency in 60-mm culture dishes. After 24 h, cells were transfected with pTet-On (BD Biosciences) by use of Lipofectamine 2000 (Invitrogen). Transfected cells were allowed to grow another 24 h and then plated in two 10-cm culture dishes, followed by G418 selection for 3 wk. Clones were isolated and transferred to 24-well culture plates to allow an additional 2 wk of growth. Individual clones were screened by luciferase assay with or without doxycycline after transfection with pTRE2hyg-Luc per the manufacturer's protocol (BD Biosciences). The clone (Tet-19) demonstrating the highest luciferase induction ratio against background by 1 µg/ml doxycycline was selected for generating the Tet-On/HNF-4{alpha} cell line.

Tet-19 cells were transfected with the pTRE-Tight plasmid containing the full-length swine HNF-4{alpha} cDNA and linear hygromycin marker by the same protocol that was used to develop the Tet-19 cell line. Both G418 (400 µg/ml) and hygromycin (300 µg/ml) were used for clone selection. After selection and expansion of clones demonstrating the highest induction of mRNA and protein secretion, as determined by real-time PCR and Western blot, the cells were used for experiments. Induction of HNF-4{alpha} secretion by differentiated cells was maximal at 6 h of incubation with each dose of doxycycline (data not shown).

Isolation of RNA. Swine tissues and IPEC-1 cells were dissolved in TRI reagent (Molecular Research Center, Cincinnati, OH) at a concentration of 50–70 mg/ml, followed by extraction of total RNA according to the manufacturer's protocol.

Semiquantitative RT-PCR. Aliquots of RNA (2–10 µg) were treated with two units of rDNase at 37°C for 30 min in 50 µl of 1x reaction buffer from the DNA-free kit (Ambion, Austin, TX). The DNase was then removed by using DNase inactive reagent from the kit. The supernatant containing 2 µg of total RNA was used in cDNA synthesis with an Omniscript RT kit (Qiagen, Santa Clarita, CA) following manufacturer's instructions. The single-strand cDNA was amplified using the Taq PCR core kit (Qiagen, Santa Clarita, CA) with 1 µl of cDNA and 50 pmol of each specific primer in a total volume of 50 µl. Primers included the following. beta-actin: forward, 5'-TGGCATTGTCATGGACTCTG-3' (sense, nt 81 to 100); reverse, 5'-CGCACTTCATGATCGAGTTG-3' (antisense, nt 471 to 490). Swine apo A-IV: forward, 5'-GAACGCCTGACCAAGGACTG-3' (sense, nt 265 to 284); reverse, 5'-CAGCTCCTCTGCCTGCTTCT-3' (antisense, nt 737 to 756). Swine apo B: forward, 5'-GAGGTAACTGTGCCTGCATA-3' (sense, nt 5596 to 5615); reverse, 5'-CTGCACTAAGGTCACGATGT-3' (antisense, nt 6031 to 6050). Swine HNF-4{alpha}: forward, 5'-AAGAAGGAAGCCGTCCAGAA-3' (sense, nt 349 to 368); reverse, 5'-CTGGCGGTCGTTGATGTAAT-3' (antisense, nt 935 to 954). Swine microsomal triglyceride transfer protein (MTP) large subunit: forward, 5'-TCATTGAAGCCCAAGGACTG-3' (sense, nt 2046 to 2065); reverse, 5'-CACTCGGGTCTTTGACTCAC-3' (antisense, nt 2389 to 2408).

After incubation for 60 s at 94°C, PCR was performed for 23 cycles for beta-actin, 25 cycles for HNF-4{alpha}, 25 cycles for apo A-IV, 29 cycles for apo B, and 27 cycles for MTP in a thermal cycler (Perkin-Elmer, Boston, MA). For each RNA sample, a negative control was run to check for DNA contamination by using AmpliTaq (Perkin-Elmer), with the sample left on ice during reverse transcription. Additionally, each reaction contained a tube with all the above buffers and enzymes but without RNA to exclude PCR product contamination. The optimal number of PCR cycles for each set of primers was established by constructing curves of number of cycles vs. PCR product band density in agarose gels. Cycle numbers were selected in the linear portion of the curves. After RT-PCR, 2/5 of the reaction products were subjected to 1.5% agarose gel electrophoresis. Expected product sizes were confirmed as follows: beta-actin, 410 bp; apo A-IV, 492 bp; apo B, 455 bp; HNF-4{alpha}, 605 bp; MTP large subunit, 336 bp. Agarose gels containing PCR products were imaged on the Gel-Doc 2000 (Bio-Rad, Hercules, CA).

Quantitative RT-PCR. Complementary DNA was prepared from RNA samples by the same protocol as described for semiquantitative PCR. The QuantiTect SYBRgreen PCR kit (Qiagen) was used for real-time PCR using the following primers. beta-actin: forward, 5'-CTCCTTCCTGGGCATGGA-3' (sense, nt 426 to 443); reverse, 5'-CGCACTTCATGATCGAGTTGA-3' (antisense, nt 470 to 490). Swine apo A-IV: forward, 5'-GGGCCACCTGAGCTTCCT-3' (sense, nt 1011 to 1028); reverse, 5'-CCTCTTTGAGGGTGCTGAAGA-3' (antisense, nt 1061 to 1081). Swine HNF-4{alpha}: forward, 5'- CTTCTTTGACCCAGATGCCAAG-3' (sense, nt 852 to 873); reverse, 5'-GGCGGTCGTTGATGTAATCCT-3' (antisense, nt 952 to 972).

Following reverse transcription, real-time quantitative PCR was performed using the Applied Biosystems Prism 7900HT sequence detection system (Applied Biosystems, Foster, CA). The following PCR profile was used: 2 min at 50°C, 10 min at 90°C and 40 cycles of 15 s at 95°C, and 60 s at 60°C. The amount of SYBRgreen was measured at the end of each cycle. Analyses were performed in duplicate. To generate the standard curves for apo A-IV, HNF-4{alpha}, and beta-actin, serially diluted cDNA was prepared, and real-time PCR was performed as above. Standard curves were generated by plotting the relative ratios of apo A-IV and HNF-4{alpha} to beta-actin gene expression.

Western blot analysis of HNF-4{alpha}. Samples of jejunal homogenate were electrophoresed and transferred to nitrocellulose filters. Western blotting was conducted using the ECL Western blot kit according to the manufacturer's protocol (Amersham Pharmacia Biotech, Piscataway, NJ). Human HNF-4{alpha} antibody was used for the swine HNF-4{alpha} blot (Santa Cruz Biotechnology, Santa Cruz, CA).

Luciferase reporter gene studies. The following PCR primers were generated from the swine apo C-III/A-IV intergenic region DNA sequence (accession no. DQ061107, GenBank): forward, 5'-TGCCTTCAGGAACATCCTGAG-3'; reverse, 5'-GCCTCCTCTAGGCCTCAGGT-3'.

A full-length apo C-III/A-IV intergenic region DNA fragment was amplified by PCR using cDNA generated from swine intestinal epithelial cell RNA. Platinum Pfx DNA polymerase (Invitrogen) was used as described in the manufacturer's protocol. The PCR product was cloned into the Zero Blunt TOPO PCR vector. The resulting plasmid was named p-C3A4.

To obtain the plasmids containing the apo C-III/A-IV intergenic region 391, 2053, and 5928 bp fragments, the apo A-IV end was amplified by PCR (Platinum Pfx DNA polymerase kit, Invitrogen) by using primers containing KpnI or MluI restriction sites using the p-C3A4 plasmid as template: forward, A-IV-Lucif-F, 5'-ATACGCGTCTTGCCTTCAGGAACATC-3'; reverse, C3A4-391-R, 5'-TTGGTACCGTCCTGTGCTCAGGTGTT-3', C3A4-2053-R, 5'-TTGGTACCGAGCTCCTCTACTCAATA-3', C3A4-5928-R, 5'-TTGGTACCGCGCCAGAGATCTAACAG-3'.

The PCR conditions were as follows: 94°C for 2 min followed by 3 cycles of 94°C for 10 s, 55°C for 15 s, 68°C for 60 s; then 25 cycles of 94°C for 10 s, 62°C for 15 s, 68°C for 60 s, and finally 68°C for 7 min. The PCR products were digested with KpnI and MluI and cloned into the corresponding sites of the firefly luciferase reporter plasmid pGL-3-basic (Promega). The integrity of all plasmids was verified by sequencing.

Tet-19 IPEC cells were cultured in normal growth medium with 5% Tet system-approved FBS. On day 1, the cells were seeded on 12-well plates at a density of 3–5 x 105 cells per well. On day 2, the cells were cotransfected with LF-2000 reagent (Invitrogen) according to manufacturer's instructions. Each well of a 12-well plate received 2 µg DNA of pGL-3-intergenic region constructs, pTRE-HNF-4{alpha} and pRL-TK at a ratio of 50:50:1. On day 3, the cells were incubated with either doxycycline 400 ng/ml or OA 0.2 mM plus doxycycline 400 ng/ml. After a 24-h incubation, the plates were washed with cold 1x PBS, then harvested and lysed with 150 µl/well 1x passive lysis buffer (dual luciferase reporter system kit, Promega) by shocking for 20–30 min at room temperature. All transfection experiments were performed in triplicate. Firefly and Renilla luciferase activities were measured using a dual-luciferase reporter assay system (Promega) and LMax microplate luminometer (Molecular Devices, Sunnyvale, CA). Data are expressed as firefly-to-Renilla luminescence ratios.

Statistical analysis. Data from two experimental groups were analyzed by Student's unpaired t-test. Data from multiple groups were analyzed by one-way ANOVA followed by the Fisher's least significant difference test to compare specific groups. Statistical significance was set at a two-tailed P value of <0.05.


   RESULTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 GRANTS
 REFERENCES
 
Swine HNF-4{alpha} derived protein sequence. Figure 1 shows the protein sequence of swine HNF-4{alpha} derived from the full-length cDNA sequence and aligned with the corresponding human sequence. The nine-amino acid NH2-terminal sequence present in swine, but not human, HNF-4{alpha} may represent variation in the translation initiation site in the swine cDNA sequence. There is >95% homology of the swine protein sequence with that of human HNF-4{alpha}. The full-length cDNA sequence was submitted to GenBank (accession no. DQ061106).


Figure 1
View larger version (28K):
[in this window]
[in a new window]

  		Fig. 1. Comparison of derived protein sequences for human (H-, top rows) and swine (P-, bottom rows) hepatocyte nuclear factor-4{alpha} (HNF-4{alpha}).

 
HNF-4{alpha} expression in developing swine. To determine the tissue distribution of HNF-4{alpha} mRNA during development, various tissues were harvested from suckling, weanling, and weaned swine and subjected to RNA extraction and conventional RT-PCR analysis. As shown in Fig. 2, the highest levels were found in liver > jejunum > kidney in all three developmental groups.


Figure 2
View larger version (28K):
[in this window]
[in a new window]

  		Fig. 2. Semiquantitative RT-PCR analysis of HNF-4{alpha} and beta-actin mRNA expression in various tissues from 2-day-old suckling, 3-wk-old weanling, and 2-mo-old weaned swine.

 
Regulation of HNF-4{alpha}, apo A-IV, apo B, and MTP mRNA expression by dietary lipid in newborn swine jejunum. We next wished to determine the effect of a high-fat intraduodenal infusion on jejunal expression of HNF-4{alpha} and apo A-IV in newborn swine. We have previously described upregulation of apo A-IV at the transcriptional level by such a diet in newborn swine over a 24-h period (30). However, we had not previously measured HNF-4{alpha} expression under these conditions. The 24-h high-fat intraduodenal infusion resulted in upregulation of both HNF-4{alpha} and apo A-IV mRNA in newborn swine jejunum measured by RT-PCR as shown in Fig. 3. The Western blot at the bottom of the figure documents that HNF-4{alpha} protein level parallels the mRNA level.


Figure 3
View larger version (59K):
[in this window]
[in a new window]

  		Fig. 3. Semiquantitative RT-PCR analysis of HNF-4{alpha}, apolipoprotein (apo) A-IV, microsomal triglyceride transfer protein (MTP) large subunit, apo B, and beta-actin mRNA and Western blot analysis of HNF-4{alpha} protein from newborn swine receiving either a high-fat or low-fat 24-h intraduodenal infusion, as described in MATERIALS AND METHODS. Results are representative of those obtained from 3 animals per group.

 
Another HNF-4{alpha} target gene is MTP (39), a heterodimer consisting of a small subunit of protein disulfide isomerase and a large subunit with lipid transfer activity, that functions to lipidate nascent chylomicrons in the endoplasmic reticulum (ER) (40). We have previously shown that MTP expression is regulated by lipid absorption in newborn swine jejunum and by oleic acid in IPEC-1 cells in a fashion similar to that of apo A-IV (27). As shown in Fig. 3, the MTP large subunit mRNA is upregulated by the high-fat infusion in a manner similar to that of apo A-IV.

Apo B-48 is another protein intimately involved in chylomicron production via lipidation by MTP as the first step in chylomicron assembly (40). In small intestine, apo B-48 mRNA is constitutively expressed, and protein levels are regulated by the net balance of proteosome-mediated degradation and rescue by lipidation. Although its gene is considered a target of HNF-4{alpha}, this mechanism is not thought to be important in physiological regulation of apo B-48 protein levels. As expected, apo B mRNA levels were not appreciably affected by the high-fat intraduodenal infusion (Fig. 3).

The time course of the upregulation of both HNF-4{alpha} and apo A-IV mRNA in newborn swine jejunum by the high-fat intraduodenal infusion, as assessed by both conventional and quantitative real-time PCR, is shown in Fig. 4. The parallel increase in both HNF-4{alpha} and apo A-IV mRNA suggests that HNF-4{alpha} induction may be involved in apo A-IV upregulation by dietary lipid. This is especially true of the more quantitative and accurate real-time PCR measurements in Fig. 4, B and C, which suggest that HNF-4{alpha} mRNA may reach maximal levels by 4 h of high-fat infusion. Also, MTP expression was induced over a time course similar to that of apo A-IV (Fig. 4).


Figure 4
View larger version (14K):
[in this window]
[in a new window]

  		Fig. 4. Time course of regulation of jejunal HNF-4{alpha}, apo A-IV, and MTP large subunit mRNA in newborn swine. A: semiquantitative RT-PCR analysis of HNF-4{alpha}, apo A-IV, MTP large subunit, and beta-actin mRNA in jejunum after 0, 4, and 24 h of intraduodenal infusion of a high-fat diet, as described in MATERIALS AND METHODS. Quantitative real-time PCR was used for measurement of jejunal HNF-4{alpha} mRNA (B) and apo A-IV mRNA (C) at the same time points. Each bar represents mean ± SE of data from samples measured in duplicate from 3 separate animals. Bars sharing the same letter are not significantly different. Those with different letters are significantly different at P < 0.05.

 
Regulation of HNF-4{alpha}, apo A-IV, and apo B expression by fatty acid in IPEC-1 cells. To determine whether the same pattern of regulation of HNF-4{alpha} and apo A-IV expression by lipid was also present in IPEC-1 cells, a cell line derived from newborn swine intestinal epithelial cells (15), IPEC-1 cells were incubated with 0.8 mM oleic acid for 24 h. This concentration is in the physiological range and maximally stimulates chylomicron triacylglycerol secretion in this cell line (15). Figure 5 shows that mRNA of both HNF-4{alpha} and apo A-IV is upregulated by oleic acid, similar to the observation in newborn swine jejunum. However, as observed in newborn swine jejunum, apo B mRNA levels did not appreciably change with oleic acid incubation.


Figure 5
View larger version (66K):
[in this window]
[in a new window]

  		Fig. 5. Regulation of HNF-4{alpha}, apo A-IV, and apo B mRNA by oleic acid (OA) treatment in IPEC-1 cells. Semiquantitative RT-PCR analysis of HNF-4{alpha}, apo A-IV, apo B, and beta-actin mRNA was performed in IPEC-1 cells incubated with (+) and without (–) OA, as described in MATERIALS AND METHODS. Results are representative of those obtained from 3 separate experiments.

 
Regulation of apo A-IV, apo B, and MTP expression by tetracycline-regulatable HNF-4{alpha} expression in the absence of fatty acid in IPEC-1 cells. To determine whether the effect of oleic acid incubation on apo A-IV expression was due directly to increased HNF-4{alpha} expression, a tetracycline-regulatable expression system was used to allow overexpression of HNF-4{alpha} in IPEC-1 cells in the absence of incubation with oleic acid to observe the effect of HNF-4{alpha} directly on apo A-IV mRNA levels in the absence of other factors that might be concomitantly induced by fatty acid absorption with potential HNF-4{alpha}-independent effects on apo A-IV expression. As shown in Fig. 6, HNF-4{alpha} induced by incubation of the cells with doxycycline in the absence of fatty acid resulted in the induction of apo A-IV mRNA. Also, swine MTP large subunit mRNA was strongly induced by HNF-4{alpha} overexpression in the absence of fatty acid. Apo B mRNA was induced to a lesser degree than that of either apo A-IV or MTP, even in the face of supraphysiological HNF-4{alpha} overexpression (Fig. 6).


Figure 6
View larger version (26K):
[in this window]
[in a new window]

  		Fig. 6. Regulation of apo A-IV, MTP large subunit, and apo B mRNA by overexpression of HNF-4{alpha} in the absence of fatty acid incubation in IPEC-1 cells. A: semiquantitative RT-PCR analysis of HNF-4{alpha}, apo A-IV, MTP large subunit, apo B, and beta-actin mRNA was performed in the absence of fatty acid incubation in IPEC-1 cells expressing swine HNF-4{alpha} driven by the tetracycline response element using the TET-On system, as described in MATERIALS AND METHODS. The concentration of doxycycline added to the culture medium is shown at bottom. Results are representative of those obtained from 3 separate experiments. Quantitative real-time PCR was used for measurement of HNF-4{alpha} mRNA (B) and apo A-IV mRNA (C) as ratios to beta-actin x 100 and 1,000, respectively, in IPEC-1 cells under the same experimental conditions. Each bar represents mean ± SE of samples measured in duplicate from 3 separate culture wells. Values for treated cells were different from those of untreated cells: aP = 0.001, bP = 0.003.

 
Activation of the apo A-IV/C-III intergenic region by HNF-4{alpha} in the presence and absence of fatty acid in IPEC-1 cells. Using three intergenic region/reporter gene constructs, cotransfected into IPEC-1 cells with doxycycline-regulatable HNF-4{alpha} expression (Fig. 7), we found that HNF-4{alpha} overexpression activated all three, with the highest activity in the largest p-5928 construct. Furthermore, treatment with 0.8 mM oleic acid did not further enhance activation of any of the constructs.


Figure 7
View larger version (16K):
[in this window]
[in a new window]

  		Fig. 7. Transcriptional activation of the swine apo A-IV/C-III intergenic region by swine HNF-4{alpha} with and without fatty acid incubation. IPEC-1 cells expressing swine HNF-4{alpha} driven by the tetracycline response element using the TET-On system were transfected with 3 DNA/luciferase reporter gene constructs spanning the swine apo A-IV/C-III intergenic region, as described in MATERIALS AND METHODS. The Basic control construct contains the luciferase reporter gene minus the intergenic region DNA sequences. Cells were treated for 24 h with or without 400 ng/ml doxycycline (DOX) and 0.8 mM oleic acid (OA). Data are expressed as firefly to Renilla luminescence ratios, and each bar represents mean ± SE for data from 3 wells. Bars sharing the same letter are not significantly different for each construct. Those with different letters are significantly different at P < 0.05.

 

   DISCUSSION
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
GRANTS
 REFERENCES
 
In the present studies, we describe a previously unreported mechanism for the transcriptional activation of the apo A-IV gene by dietary lipid in the newborn swine proximal small intestine. Data from newborn swine feeding studies and in vitro swine enterocyte culture experiments suggest that absorbed dietary fatty acids result in the upregulation of levels of HNF-4{alpha} mRNA and protein, which then activates apo A-IV gene transcription without evidence for the direct activation of HNF-4{alpha} by ligand binding of fatty acid. This regulatory mechanism was unexpected but may be important in the striking induction of jejunal apo A-IV expression by dietary lipid in the neonatal piglet, a model for the human infant.

Recent studies have defined a role for HNF-4{alpha} in the transcriptional regulation of apo A-IV in the enterocyte, including the basal spatial expression of apo A-IV in the small intestine with restriction of expression to the villus and a proximal to distal gradient via interaction with the apo A-IV gene proximal promoter and distal apo C-III gene enhancer located in the apo A-IV/C-III intergenic region (2, 37). Peignon et al. (32) demonstrated that E-cadherin-dependent cell adhesion in Caco-2 cells controls the abundance of HNF-4{alpha}, which in turn regulates apo A-IV expression. Although HNF-4{alpha} abundance was modulated in their studies by cell adhesion and differentiation, this is not likely to have been a factor in the present experiments, since in both the in vivo and in vitro experiments enterocytes were stably differentiated and appropriate untreated controls were used.

Data from previously reported studies supporting a role for HNF-4{alpha} participation in dietary lipid-mediated regulation of intestinal apo A-IV transcription are scarce. Recently, lipid micelles containing fatty acids incubated in the apical medium compartment of Caco-2 cells were shown to enhance apo A-IV transcription and simultaneously activate reporter gene constructs containing the apo A-IV proximal promoter/apo C-III distal enhancer (9). This effect was blocked by transfection with a dominant negative form of HNF-4{alpha}. Interestingly, oleic acid2-monooleoylglycerol-taurocholate-lysophosphatidylcholine- cholesterol micelles were effective in inducing apo A-IV mRNA, whereas the individual micellar components were not. Also in these previous experiments, increased binding of HNF-4{alpha} to apo A-IV promoter/C-III enhancer DNA binding sites was demonstrated by electrophoretic mobility shift assays after treatment with lipid micelles. Whether this effect was due to increased HNF-4{alpha} binding affinity or increased HNF-4{alpha} abundance was not addressed. In the present studies, oleic acid/BSA complexes were used to deliver fatty acids to the apical membrane of the IPEC-1 cells and effectively induced HNF-4{alpha} and apo A-IV mRNA. However, in the newborn swine studies, mixed micelles would have delivered the infused lipid to the small intestinal mucosa. In the high-fat formula used in the piglet infusion experiments, as well as in the cell culture experiments using oleic acid, 18-carbon unsaturated fatty acids were used. Taken together, these data suggest that this class of fatty acids is effective in the coordinate induction of both HNF-4{alpha} and apo A-IV expression in newborn swine enterocytes.

In addition to induction of HNF-4{alpha} expression by fatty acid as a mechanism of lipid-mediated regulation of apo A-IV expression, in the present studies we also addressed the issue of whether fatty acid can also directly activate HNF-4{alpha} transcriptional activity. By use of the TET-On system, swine HNF-4{alpha} was overexpressed in IPEC-1 cells in the absence of oleic acid treatment and resulted in the induction of apo A-IV mRNA. Furthermore, in swine apo A-IV/C-III intergenic region/luciferase reporter gene experiments in the absence of added fatty acid, this overexpression of HNF-4{alpha} demonstrated striking transcriptional activation of the apo A-IV gene, presumably mediated by ligand-independent HNF-4{alpha} transactivation. As in the human, the swine apo A-IV/C-III intergenic region contains several consensus HNF-4{alpha} binding sequences that are probably involved in this regulation. With oleic acid treatment, this activation was not further enhanced, suggesting that oleic acid does not significantly modulate the HNF-4{alpha} transcriptional activity by presumed ligand binding.

The mechanism of induction of HNF-4{alpha} mRNA by lipid absorption is unknown at present. The HNF-4{alpha} gene may be activated by transcription factors that bind fatty acids as ligands or via a signaling mechanism activated by fatty acids. Studies of the transcriptional regulation of HNF-4{alpha} have provided insight into non-lipid-mediated mechanisms. Two different promoters appear to drive HNF-4{alpha} expression in a tissue-specific manner. The proximal P1 promoter regulates expression in adult liver and kidney (50), and the P1 promoter and a distal P2 enhancer direct expression in embryonic liver and adult pancreatic beta-cells (13, 44). These regulatory elements mediate transcriptional regulation via several transcription factors, including HNF-1{alpha}, HNF-1beta, HNF-3, CCAAT/enhancer binding protein (C/EBP), Sp1, chicken ovalbumin upstream promoter-transcription factor 2 (COUP-TFII), retinoic acid receptor-{alpha} (RAR{alpha}), retinoid-X receptor-{alpha} (RXR{alpha}), HNF-6, and GATA-6. It has also been shown that HNF-4{alpha} autoregulates its own expression in liver (31). It is currently unknown whether any of these regulatory factors might be lipid responsive in small intestine. Alternatively, fatty acid-mediated regulation of HNF-4{alpha} mRNA levels might occur by regulation of mRNA transcript stability. The basis for regulation of HNF-4{alpha} expression in intestine by dietary fatty acids, especially potentially involving P1 and P2, is the focus of ongoing studies in our laboratory.

There are undoubtedly other HNF-4{alpha}-dependent and -independent mechanisms involved in the induction of apo A-IV by dietary lipid in small intestine. Modulation of HNF-4{alpha} transcriptional activity for various target genes, including apo A-IV in some instances, has been demonstrated to be mediated by phosphorylation (24), as well as interaction with other proteins, including peroxisome proliferator-activated receptor-{gamma} coactivator 1{alpha} (PGC-1{alpha}) (16, 34, 35, 48), sterol regulatory element-binding protein (SREBP) (47), and small heterodimer partner (SHP) (41). However, to date these proteins have not been implicated in dietary lipid-mediated regulation. Recently, estrogen-regulated receptor-{alpha} (ERR{alpha}) was shown to regulate several genes involved in lipid transport in the small intestine, including apo A-IV, and ERR{alpha}–/– mice were found to have significant fat malabsorption (8). However, feeding-induced regulation of apo A-IV expression was not observed, even though ERR{alpha} regulated basal apo A-IV expression in cooperation with PGC-1{alpha}. Finally, we recently identified a novel putative repressor protein that binds to the proximal promoter of the swine apo A-IV gene that may regulate apo A-IV expression in jejunum during lipid absorption in newborn piglets fed a high-fat diet (30). Identification of other dietary lipid-specific factors that regulate apo A-IV in the intestine awaits further study.

Finally, in addition to apo A-IV, there are other genes involved in intestinal lipid transport that are HNF-4{alpha} targets that may also be activated by lipid-mediated HNF-4{alpha} induction and thereby enhance intestinal lipid absorption in concert with apo A-IV. These include MTP that serves to lipidate apo B-48 as the first step in chylomicron assembly, as well as in the subsequent addition of bulk lipid to the nascent chylomicron in the ER (39, 40). We have previously shown that MTP large subunit expression is regulated by lipid absorption in newborn swine jejunum and by oleic acid in IPEC-1 cells in a fashion similar to that of apo A-IV (27). In the present studies we documented that the MTP large subunit gene is indeed a specific target of overexpressed HNF-4{alpha} in the absence of fatty acid, similar to apo A-IV.

We also examined the effect of HNF-4{alpha} overexpression of apo B mRNA levels. Although supraphysiological HNF-4{alpha} overexpression increased apo B mRNA levels, the magnitude was less than that of apo A-IV and MTP large subunit. Also, the intraduodenal infusion of a high-fat formula in newborn swine and oleic acid treatment of IPEC-1 cells did not appear to significantly alter apo B mRNA levels, despite striking increases in HNF-4{alpha}, apo A-IV, and MTP large subunit mRNA levels. These observations, coupled with the fact that apo B-48 protein levels are generally regulated at the posttranslational level, make it unlikely that HNF-4{alpha} is a physiological regulator of apo B, despite the presence of HNF-4{alpha} binding sites in apo B gene regulatory elements (49). Although not addressed in the present report, liver fatty acid binding protein has been demonstrated to be regulated by HNF-4{alpha} in liver and is also expressed in the enterocyte, where it may function in fatty acid trafficking (20, 36).

In conclusion, the present studies demonstrated coordinate upregulation of both HNF-4{alpha} and apo A-IV expression by lipid absorption in newborn swine proximal small intestine. Furthermore, the same pattern of upregulation was present in IPEC-1 cells derived from newborn swine small intestinal epithelial cells. Fatty acid-independent overexpression of HNF-4{alpha} in IPEC-1 cells induced apo A-IV expression at the transcriptional level, and fatty acid treatment did not further enhance this transcriptional activation. These data suggest that the acute induction of the apo A-IV gene by dietary lipid in newborn intestine may occur, at least in part, via ligand-independent transactivation by HNF-4{alpha} that is itself induced by a lipid-mediated mechanism. Absorbed fatty acids may induce enterocyte apo A-IV expression via induction of HNF-4{alpha} in newborn small intestine as a novel mechanism to enhance small intestinal lipid absorption. This enhancement would occur via the assembly and secretion of larger chylomicrons mediated by increased availability of apo A-IV, as we have demonstrated previously (28, 29). This enhancement may be augmented by upregulation of other HNF-4{alpha} target genes involved in lipid absorption, such as MTP. Thus HNF-4{alpha} may serve as a "master switch" for coordinating chylomicron assembly in the newborn.


   GRANTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
REFERENCES
 
This work was supported by National Institute of Child Health and Human Development Grant HD-22551 (D. D. Black) and by the Children's Foundation Research Center of Memphis at Le Bonheur Children's Medical Center (D. D. Black).


   FOOTNOTES
 

Address for reprint requests and other correspondence: D. D. Black, Children's Foundation Research Center of Memphis, Le Bonheur Children's Medical Center, Rm. 401, W. Patient Tower, 50 N. Dunlap, Memphis, TN 38103 (e-mail: dblack{at}utmem.edu)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


   REFERENCES
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. Apfelbaum TF, Davidson NO, Glickman RM. Apolipoprotein A-IV synthesis in the rat small intestine: regulation by dietary triglyceride. Am J Physiol Gastrointest Liver Physiol 252: G662–G666, 1987.[Abstract/Free Full Text]
  2. Archer A, Sauvaget D, Chauffeton V, Bouchet PE, Chambaz J, Pincon-Raymond M, Cardot P, Ribeiro A, Lacasa M. Intestinal apolipoprotein A-IV gene transcription is controlled by two hormone-responsive elements: a role for hepatic nuclear factor-4 isoforms. Mol Endocrinol 19: 2320–2334, 2005.[Abstract/Free Full Text]
  3. Black DD. Regulation of intestinal apolipoprotein gene expression. In: Intestinal Lipid Metabolism, edited by Mansbach CM, Tso P, and Kuksis A. New York: Kluwer Academic/Plenum, 2001, p. 263–284.
  4. Black DD, Rohwer-Nutter PL. Intestinal apolipoprotein synthesis in the newborn piglet. Pediatr Res 29: 32–38, 1991.[Web of Science][Medline]
  5. Black DD, Rohwer-Nutter PL, Davidson NO. Intestinal apo A-IV gene expression in the piglet. J Lipid Res 31: 497–505, 1990.[Abstract]
  6. Black DD, Wang H, Hunter F, Zhan R. Intestinal expression of apolipoprotein A-IV and C-III is coordinately regulated by dietary lipid in newborn swine. Biochem Biophys Res Commun 221: 619–624, 1996.[CrossRef][Web of Science][Medline]
  7. Bogan AA, Dallas-Yang Q, Ruse MD Jr, Maeda Y, Jiang G, Nepomuceno L, Scanlan TS, Cohen FE, Sladek FM. Analysis of protein dimerization and ligand binding of orphan receptor HNF-4alpha. J Mol Biol 302: 831–851, 2000.[CrossRef][Web of Science][Medline]
  8. Carrier JC, Deblois G, Champigny C, Levy E, Giguere V. Estrogen-related receptor alpha (ERRalpha) is a transcriptional regulator of apolipoprotein A-IV and controls lipid handling in the intestine. J Biol Chem 279: 52052–52058, 2004.[Abstract/Free Full Text]
  9. Carriere V, Vidal R, Lazou K, Lacasa M, Delers F, Ribeiro A, Rousset M, Chambaz J, Lacorte JM. HNF-4-dependent induction of apolipoprotein A-IV gene transcription by an apical supply of lipid micelles in intestinal cells. J Biol Chem 280: 5406–5413, 2005.[Abstract/Free Full Text]
  10. Dhe-Paganon S, Duda K, Iwamoto M, Chi YI, Shoelson SE. Crystal structure of the HNF-4 alpha ligand binding domain in complex with endogenous fatty acid ligand. J Biol Chem 277: 37973–37976, 2002.[Abstract/Free Full Text]
  11. Duverger N, Tremp G, Gaillaud JM, Emmanuel F, Castro G, Fruchart JC, Steinmetz A, Denefle P. Protection against atherogenesis in mice mediated by human apolipoprotein A-IV. Science 273: 966–968, 1996.[Abstract]
  12. Dvorin E, Gorder NL, Benson DM, Gotto AM. Apolipoprotein A-IV: a determinate for binding and uptake of high-density lipoproteins by rat hepatocytes. J Biol Chem 261: 15714–15718, 1986.[Abstract/Free Full Text]
  13. Eeckhoute J, Moerman E, Bouckenooghe T, Lukoviak B, Pattou F, Formstecher P, Kerr-Conte J, Vandewalle B, Laine B. Hepatocyte nuclear factor-4 alpha isoforms originated from the P1 promoter are expressed in human pancreatic beta-cells and exhibit stronger transcriptional potentials than P2 promoter-driven isoforms. Endocrinology 144: 1686–1694, 2003.[Abstract/Free Full Text]
  14. Fujimoto K, Cardelli JA, Tso P. Increased apolipoprotein A-IV in rat mesenteric lymph after lipid meal acts as a physiological signal for satiation. Am J Physiol Gastrointest Liver Physiol 262: G1002–G1006, 1992.[Abstract/Free Full Text]
  15. Gonzalez-Vallina R, Wang H, Zhan R, Berschneider HM, Lee RM, Davidson NO, Black DD. Lipoprotein and apolipoprotein secretion by a newborn piglet intestinal cell line (IPEC-1). Am J Physiol Gastrointest Liver Physiol 271: G249–G259, 1996.[Abstract/Free Full Text]
  16. Hanniman EA, Lambert G, Inoue Y, Gonzalez FJ, Sinal CJ. Apolipoprotein A-IV is regulated by nutritional and metabolic stress: involvement of glucocorticoids, HNF-4 alpha, and PGC-1 alpha. J Lipid Res 47: 2503–2514, 2006.[Abstract/Free Full Text]
  17. Hayhurst GP, Lee YH, Lambert G, Ward JM, Gonzalez FJ. Hepatocyte nuclear factor-4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Cell Biol 21: 1393–1403, 2001.[Abstract/Free Full Text]
  18. Hertz R, Magenheim J, Berman I, Bar-Tana J. Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4 alpha. Nature 392: 512–516, 1998.[CrossRef][Medline]
  19. Hertz R, Sheena V, Kalderon B, Berman I, Bar-Tana J. Suppression of hepatocyte nuclear factor-4alpha by acyl-CoA thioesters of hypolipidemic peroxisome proliferators. Biochem Pharmacol 61: 1057–1062, 2001.[CrossRef][Web of Science][Medline]
  20. Hsu KT. Fatty acid transfer from liver and intestinal fatty acid-binding proteins to membranes occurs by different mechanisms. J Biol Chem 271: 13317–13323, 1996.[Abstract/Free Full Text]
  21. Jump DB. Fatty acid regulation of gene transcription. Crit Rev Clin Lab Sci 41: 41–78, 2004.[CrossRef][Web of Science][Medline]
  22. Kalogeris TJ, Rodriguez MD, Tso P. Control of synthesis and secretion of intestinal apolipoprotein A-IV by lipid. J Nutr 127: 537S–543S, 1997.[Medline]
  23. Karathanasis SK. Apolipoprotein multigene family: tandem organization of human apolipoprotein AI, CIII, and AIV genes. Proc Natl Acad Sci USA 82: 6374–6378, 1985.[Abstract/Free Full Text]
  24. Ktistaki E, Ktistakis NT, Papadogeorgaki E, Talianidis I. Recruitment of hepatocyte nuclear factor-4 into specific intranuclear compartments depends on tyrosine phosphorylation that affects its DNA-binding and transactivation potential. Proc Natl Acad Sci USA 92: 9876–9880, 1995.[Abstract/Free Full Text]
  25. Ktistaki E, Lacorte JM, Katrakili N, Zannis VI, Talianidis I. Transcriptional regulation of the apolipoprotein A-IV gene involves synergism between a proximal orphan receptor response element and a distant enhancer located in the upstream promoter region of the apolipoprotein A-IV gene. Nucleic Acids Res 22: 4689–4696, 1994.[Abstract/Free Full Text]
  26. Le Beyec J, Chauffeton V, Kan HY, Janvier PL, Cywiner-Golenzer C, Chatelet FP, Kalopissis AD, Zannis V, Chambaz J, Pincon-Raymond M, Cardot P. The –700/–310 fragment of the apolipoprotein A-IV gene combined with the –890/–500 apolipoprotein C-III enhancer is sufficient to direct a pattern of gene expression similar to that for the endogenous apolipoprotein A-IV gene. J Biol Chem 274: 4954–4961, 1999.[Abstract/Free Full Text]
  27. Lu S, Huffman M, Yao Y, Mansbach CM, Cheng X, Black DD. Regulation of microsomal triglyceride transfer protein expression in developing swine. J Lipid Res 43: 1303–1311, 2002.[Abstract/Free Full Text]
  28. Lu S, Yao Y, Cheng X, Mitchell S, Leng S, Meng S, Gallagher JW, Shelness GS, Morris GS, Mahan J, Frase S, Mansbach CM, Weinberg RB, Black DD. Overexpression of apolipoprotein A-IV enhances lipid secretion in IPEC-1 cells by increasing chylomicron size. J Biol Chem 281: 3473–3483, 2006.[Abstract/Free Full Text]
  29. Lu S, Yao Y, Meng S, Cheng X, Black DD. Overexpression of apolipoprotein A-IV enhances lipid transport in newborn swine intestinal epithelial cells. J Biol Chem 277: 31929–31937, 2002.[Abstract/Free Full Text]
  30. Lu S, Yao Y, Wang H, Meng S, Cheng X, Black DD. Regulation of apo A-IV transcription by lipid in newborn swine is associated with a promoter DNA-binding protein. Am J Physiol Gastrointest Liver Physiol 284: G248–G254, 2003.[Abstract/Free Full Text]
  31. Magenheim J, Hertz R, Berman I, Nousbeck J, Bar-Tana J. Negative autoregulation of HNF-4alpha gene expression by HNF-4alpha1. Biochem J 388: 325–332, 2005.[CrossRef][Web of Science][Medline]
  32. Peignon G, Thenet S, Schreider C, Fouquet S, Ribeiro A, Dussaulx E, Chambaz J, Cardot P, Pincon-Raymond M, Le Beyec J. E-cadherin-dependent transcriptional control of apolipoprotein A-IV gene expression in intestinal epithelial cells: a role for the hepatic nuclear factor-4. J Biol Chem 281: 3560–3568, 2006.[Abstract/Free Full Text]
  33. Qin X, Swertfeger DK, Zheng S, Hui DY, Tso P. Apolipoprotein A-IV: A potent endogenous inhibitor of lipid oxidation. Am J Physiol Heart Circ Physiol 274: H1836–H1840, 1998.[Abstract/Free Full Text]
  34. Rhee J, Ge H, Yang W, Fan M, Handschin C, Cooper M, Lin J, Li C, Spiegelman BM. Partnership of PGC-1alpha and HNF-4alpha in the regulation of lipoprotein metabolism. J Biol Chem 281: 14683–14690, 2006.[Abstract/Free Full Text]
  35. Rhee J, Inoue Y, Yoon JC, Puigserver P, Fan M, Gonzalez FJ, Spiegelman BM. Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor-4alpha in gluconeogenesis. Proc Natl Acad Sci USA 100: 4012–4017, 2003.[Abstract/Free Full Text]
  36. Rowley CW, Staloch LJ, Divine JK, McCaul SP, Simon TC. Mechanisms of mutual functional interactions between HNF-4alpha and HNF-1alpha revealed by mutations that cause maturity onset diabetes of the young. Am J Physiol Gastrointest Liver Physiol 290: G466–G475, 2006.[Abstract/Free Full Text]
  37. Sauvaget D, Chauffeton V, Citadelle D, Chatelet FP, Cywiner-Golenzer C, Chambaz J, Pincon-Raymond M, Cardot P, Le Beyec J, Ribeiro A. Restriction of apolipoprotein A-IV gene expression to the intestine villus depends on a hormone-responsive element and parallels differential expression of the hepatic nuclear factor-4alpha and gamma isoforms. J Biol Chem 277: 34540–34548, 2002.[Abstract/Free Full Text]
  38. Seda O, Sedova L. New apolipoprotein A-V: comparative genomics meets metabolism. Physiol Res 52: 141–146, 2003.[Web of Science][Medline]
  39. Sheena V, Hertz R, Nousbeck J, Berman I, Magenheim J, Bar-Tana J. Transcriptional regulation of human microsomal triglyceride transfer protein by hepatocyte nuclear factor-4alpha. J Lipid Res 46: 328–341, 2005.[Abstract/Free Full Text]
  40. Shelness GS, Ledford AS. Evolution and mechanism of apolipoprotein B-containing lipoprotein assembly. Curr Opin Lipidol 16: 325–332, 2005.[Web of Science][Medline]
  41. Shimamoto Y, Ishida J, Yamagata K, Saito T, Kato H, Matsuoka T, Hirota K, Daitoku H, Nangaku M, Yamagata K, Fujii H, Takeda J, Fukamizu A. Inhibitory effect of the small heterodimer partner on hepatocyte nuclear factor-4 mediates bile acid-induced repression of the human angiotensinogen gene. J Biol Chem 279: 7770–7776, 2004.[Abstract/Free Full Text]
  42. Sladek FM, Seidel SD. Hepatocyte nuclear factor-4 alpha. In: Nuclear Receptors and Genetic Disease, edited by Burris TB and McCabe ERB. San Diego, CA: Academic, 2001, p. 309–361.
  43. Stegmann A, Hansen M, Wang Y, Larsen JB, Lund LR, Ritie L, Nicholson JK, Quistorff B, Simon-Assmann P, Troelsen JT, Olsen J. Metabolome, transcriptome, and bioinformatic cis-element analyses point to HNF-4 as a central regulator of gene expression during enterocyte differentiation. Physiol Genomics 27: 141–155, 2006.[Abstract/Free Full Text]
  44. Thomas H, Jaschkowitz K, Bulman M, Frayling TM, Mitchell SM, Roosen S, Lingott-Frieg A, Tack CJ, Ellard S, Ryffel GU, Hattersley AT. A distant upstream promoter of the HNF-4alpha gene connects the transcription factors involved in maturity-onset diabetes of the young. Hum Mol Genet 10: 2089–2097, 2001.[Abstract/Free Full Text]
  45. Vowinkel T, Mori M, Krieglstein CF, Russell J, Saijo F, Bharwani S, Turnage RH, Davidson WS, Tso P, Granger DN, Kalogeris TJ. Apolipoprotein A-IV inhibits experimental colitis. J Clin Invest 114: 260–269, 2004.[CrossRef][Web of Science][Medline]
  46. Wisely G, Miller A, Davis R, Thornquest A, Johnson R, Spitzer T, Sefler A, Shearer B, Moore J, Willson T, Williams S. Hepatocyte nuclear factor-4 is a transcription factor that constitutively binds fatty acids. Structure 10: 1225–1234, 2002.[Medline]
  47. Yamamoto T, Shimano H, Nakagawa Y, Ide T, Yahagi N, Matsuzaka T, Nakakuki M, Takahashi A, Suzuki H, Sone H, Toyoshima H, Sato R, Yamada N. SREBP-1 interacts with hepatocyte nuclear factor-4 alpha and interferes with PGC-1 recruitment to suppress hepatic gluconeogenic genes. J Biol Chem 279: 12027–12035, 2004.[Abstract/Free Full Text]
  48. Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J, Adelmant G, Stafford J, Kahn CR, Granner DK, Newgard CB, Spiegelman BM. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413: 131–138, 2001.[CrossRef][Medline]
  49. Zannis VI, Kan HY, Kritis A, Zanni E, Kardassis D. Transcriptional regulation of the human apolipoprotein genes. Front Biosci 6: 456–501, 2001.[CrossRef]
  50. Zhong W, Mirkovitch J, Darnell JE Jr. Tissue-specific regulation of mouse hepatocyte nuclear factor-4 expression. Mol Cell Biol 14: 7276–7284, 1994.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
N. Yamaguchi, S. Miyamoto, Y. Ogura, T. Goda, and K. Suruga
Hepatocyte nuclear factor-4{alpha} regulates human cellular retinol-binding protein type II gene expression in intestinal cells
Am J Physiol Gastrointest Liver Physiol, March 1, 2009; 296(3): G524 - G533.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
O. Beaslas, F. Torreilles, P. Casellas, D. Simon, G. Fabre, M. Lacasa, F. Delers, J. Chambaz, M. Rousset, and V. Carriere
Transcriptome response of enterocytes to dietary lipids: impact on cell architecture, signaling, and metabolism genes
Am J Physiol Gastrointest Liver Physiol, November 1, 2008; 295(5): G942 - G952.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/2/G475    most recent
00072.2007v2
00072.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leng, S.
Right arrow Articles by Black, D. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leng, S.
Right arrow Articles by Black, D. D.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.